Comparison of Treatment Regimens Using Ranibizumab: Intensive (Resolution of Intra- and Sub-retinal Fluid) vs Relaxed (Resolution of Intra-retinal Fluid and/or Sub-retinal Fluid >200µm at the Foveal Centre)
Clinical trial NCT01972789 · COMPLETED
Trial details
- NCT number
- NCT01972789
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-31
- Primary completion
- 2017-02-28
- Enrollment
- 349
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.